Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Valion Bio (TIVC) FCF Margin (2021 - 2025)

Valion Bio has reported FCF Margin over the past 5 years, most recently at 1384.93% for Q3 2025.

  • For Q3 2025, FCF Margin fell 23652.0% year-over-year to 1384.93%; the TTM value through Sep 2025 reached 1254.56%, down 60942.0%, while the annual FY2024 figure was 733.97%, 22.0% down from the prior year.
  • FCF Margin for Q3 2025 was 1384.93% at Valion Bio, up from 2105.81% in the prior quarter.
  • Over five years, FCF Margin peaked at 202.61% in Q2 2021 and troughed at 2105.81% in Q2 2025.
  • A 5-year average of 794.74% and a median of 651.42% in 2023 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: tumbled -122580bps in 2023 and later soared 65655bps in 2024.
  • Year by year, FCF Margin stood at 709.51% in 2021, then increased by 23bps to 545.83% in 2022, then increased by 9bps to 496.92% in 2023, then crashed by -48bps to 736.11% in 2024, then tumbled by -88bps to 1384.93% in 2025.
  • Business Quant data shows FCF Margin for TIVC at 1384.93% in Q3 2025, 2105.81% in Q2 2025, and 1270.0% in Q1 2025.